Kenneth A. Myszkowski

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ARWR

Current role

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Arrowhead Pharmaceuticals, Inc. (ARWR)	Chief Financial Officer	$592,369	—	$2,589,750	—	$314,496	$15,761	$3,512,376
2023	Arrowhead Pharmaceuticals, Inc. (ARWR)	Chief Financial Officer	$568,128	—	$2,284,800	—	$252,000	$14,215	$3,119,143
2022	Arrowhead Pharmaceuticals, Inc. (ARWR)	Chief Financial Officer	$509,648	—	$3,978,000	—	$238,106	$13,798	$4,739,552
2021	Arrowhead Pharmaceuticals, Inc. (ARWR)	Chief Financial Officer	$484,865	—	$4,603,800	—	$231,171	$13,734	$5,333,570
2020	Arrowhead Pharmaceuticals, Inc. (ARWR)	Chief Financial Officer	$463,750	—	$5,391,550	—	$213,750	$12,802	$6,081,852

No earnings-call appearances or filed executive changes recorded yet.